China Resources Pharmaceuticals (03320): China Resources's net profit to mother in the first half of 2019 was about 1,671 billion yuan, a year-on-year decrease of 7.96%

Zhitong Finance App News, China Resources Pharmaceutical (03320) announced China Resources 39's 2026 interim results, with total operating revenue of about 15.014 billion yuan, up 1.37% year on year; net profit attributable to shareholders of listed companies was about 1,671 billion yuan, a year-on-year decrease of 7.96%; basic profit per share was 1 yuan, with a cash dividend of 4.15 yuan (tax included) for every 10 shares